123 related articles for article (PubMed ID: 12569028)
21. Cross-linked chitosan microspheres: preparation and evaluation as a matrix for the controlled release of pharmaceuticals.
Thanoo BC; Sunny MC; Jayakrishnan A
J Pharm Pharmacol; 1992 Apr; 44(4):283-6. PubMed ID: 1355537
[TBL] [Abstract][Full Text] [Related]
22. Formulation and evaluation of novel tableted chitosan microparticles for the controlled release of clozapine.
Agnihotri SA; Aminabhavi TM
J Microencapsul; 2004 Nov; 21(7):709-18. PubMed ID: 15799221
[TBL] [Abstract][Full Text] [Related]
23. The design of biodegradable ofloxacin-based core-shell microspheres: influence of the formulation parameters on in vitro characterization.
Sezer AD; Akbuğa J
Pharm Dev Technol; 2012; 17(1):118-24. PubMed ID: 20977313
[TBL] [Abstract][Full Text] [Related]
24. Preparation and evaluation of sustained release cross-linked chitosan microspheres containing phenobarbitone.
al-Helw AA; Al-Angary AA; Mahrous GM; al-Dardari MM
J Microencapsul; 1998; 15(3):373-82. PubMed ID: 9608399
[TBL] [Abstract][Full Text] [Related]
25. Microencapsulation of protein drugs for drug delivery: strategy, preparation, and applications.
Ma G
J Control Release; 2014 Nov; 193():324-40. PubMed ID: 25218676
[TBL] [Abstract][Full Text] [Related]
26. Development of poly(Lactic acid)/chitosan co-matrix microspheres: controlled release of taxol-heparin for preventing restenosis.
Chandy T; Rao GH; Wilson RF; Das GS
Drug Deliv; 2001; 8(2):77-86. PubMed ID: 11400866
[TBL] [Abstract][Full Text] [Related]
27. Crosslinked chitosan microspheres for encapsulation of diclofenac sodium: effect of crosslinking agent.
Kumbar SG; Kulkarni AR; Aminabhavi M
J Microencapsul; 2002; 19(2):173-80. PubMed ID: 11837972
[TBL] [Abstract][Full Text] [Related]
28. Chitosan: properties, preparations and application to microparticulate systems.
Kaş HS
J Microencapsul; 1997; 14(6):689-711. PubMed ID: 9394251
[TBL] [Abstract][Full Text] [Related]
29. Ionotropic cross-linked chitosan microspheres for controlled release of ampicillin.
Anal AK; Stevens WF; Remuñán-López C
Int J Pharm; 2006 Apr; 312(1-2):166-73. PubMed ID: 16497452
[TBL] [Abstract][Full Text] [Related]
30. Modulation of stability and mucoadhesive properties of chitosan microspheres for therapeutic gastric application.
Fernandes M; Gonçalves IC; Nardecchia S; Amaral IF; Barbosa MA; Martins MC
Int J Pharm; 2013 Sep; 454(1):116-24. PubMed ID: 23850814
[TBL] [Abstract][Full Text] [Related]
31. Optimizing formulation factors in preparing chitosan microparticles by spray-drying method.
Huang YC; Chiang CH; Yeh MK
J Microencapsul; 2003; 20(2):247-60. PubMed ID: 12554378
[TBL] [Abstract][Full Text] [Related]
32. Chitosan microparticle preparation for controlled drug release by response surface methodology.
Ko JA; Park HJ; Park YS; Hwang SJ; Park JB
J Microencapsul; 2003; 20(6):791-7. PubMed ID: 14594667
[TBL] [Abstract][Full Text] [Related]
33. Formulation and in vivo evaluation of chlorhexidine buccal tablets prepared using drug-loaded chitosan microspheres.
Giunchedi P; Juliano C; Gavini E; Cossu M; Sorrenti M
Eur J Pharm Biopharm; 2002 Mar; 53(2):233-9. PubMed ID: 11880008
[TBL] [Abstract][Full Text] [Related]
34. Alternate polyelectrolyte coating of chitosan beads for extending drug release.
Srinatha A; Pandit JK
Drug Deliv; 2008; 15(3):193-9. PubMed ID: 18379932
[TBL] [Abstract][Full Text] [Related]
35. Effect of magnesium stearate on chitosan microspheres prepared by an emulsification-coacervation technique.
Lim LY; Wan LS
J Microencapsul; 1998; 15(3):319-33. PubMed ID: 9608395
[TBL] [Abstract][Full Text] [Related]
36. Controlled drug delivery systems based on thiolated chitosan microspheres.
Elhassan Imam M; Bernkop-Schnürch A
Drug Dev Ind Pharm; 2005 Jul; 31(6):557-65. PubMed ID: 16109629
[TBL] [Abstract][Full Text] [Related]
37. Comparison of chitosan and gelatin coated microparticles: prepared by hot-melt method.
Lin WJ; Kang WW
J Microencapsul; 2003; 20(2):169-77. PubMed ID: 12554372
[TBL] [Abstract][Full Text] [Related]
38. Stomach-specific anti-H. pylori therapy. I: Preparation and characterization of tetracyline-loaded chitosan microspheres.
Hejazi R; Amiji M
Int J Pharm; 2002 Mar; 235(1-2):87-94. PubMed ID: 11879743
[TBL] [Abstract][Full Text] [Related]
39. Nifedipine loaded chitosan microspheres prepared by emulsification phase-separation.
Dhawan S; Singla AK
Biotech Histochem; 2003 Oct; 78(5):243-54. PubMed ID: 14989642
[TBL] [Abstract][Full Text] [Related]
40. Different molecular weight chitosan microspheres: influence on drug loading and drug release.
Genta I; Perugini P; Pavanetto F
Drug Dev Ind Pharm; 1998 Aug; 24(8):779-84. PubMed ID: 9876526
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
